Joy Aligo Bimmangon, | |
19617 Hillside Ave, Hollis, NY 11423-2157 | |
(718) 479-3900 | |
(718) 479-1014 |
Full Name | Joy Aligo Bimmangon |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 19617 Hillside Ave, Hollis, New York |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316681596 | NPI | - | NPPES |
038237-01 | Other | NY | REGISTRATION CERTIFICATE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 038237-01 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Joy Aligo Bimmangon, 19617 Hillside Ave, Hollis, NY 11423-2157 Ph: (718) 479-3900 | Joy Aligo Bimmangon, 19617 Hillside Ave, Hollis, NY 11423-2157 Ph: (718) 479-3900 |
News Archive
Medical errors are estimated to cause 250,000 deaths per year in the US. Previously, research on admitted patients suggested that errors are due to the way doctors process the data they have about patients - in other words, doctors have the right information, but might not act on it in the best way.
Drowning is a global threat to human health. Each year, more than 372,000 people die as a result of drowning, with many of those deaths being preventable by simple water safety measures. In order to arm professionals with the most up-to-date clinical protocols, the Wilderness Medical Society has issued a new set of practice guidelines for both the treatment and prevention of drowning, published in the society's official journal, Wilderness and Environmental Medicine.
Nabriva Therapeutics AG, a biotechnology company focused on developing pleuromutilins, a new class of antibiotics for the treatment of serious infections caused by resistant Gram-positive and Gram-negative pathogens, announced today that the United States Food and Drug Administration has granted Qualified Infectious Disease Product (QIDP) as well as Fast Track status designation to Nabriva's lead product lefamulin, for the treatment of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI).
In a new study published today in JCI Insight, UC Davis researchers have shown that combining high-intensity focused ultrasound with two immunotherapies (a PD-1 checkpoint inhibitor and TLR9 agonist) can produce excellent response rates in mouse models of epithelial cancer.
Canadian researchers have shown that patients who receive early treatment for Hepatitis C virus (HCV) within the first months following an infection, develop a rapid poly-functional immune response against HCV similar to when infection is erradicted spontaneously, according to a new study published in the Journal of Virology.
› Verified 4 days ago
Superior Physical Therapy, P.c. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8648 Marengo St, Hollis, NY 11423 Phone: 917-880-6390 Fax: 718-776-8975 | |
Moamen Mohamed Hassanen, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 204-12 Hillside Ave, Hollis, NY 11423 Phone: 718-749-5800 | |
Dr. Ari Levine, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 8055 189th St, Hollis, NY 11423 Phone: 917-287-5127 Fax: 718-282-1955 | |
Mr. Durojaiye Shadrach Ojetayo, P.T Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 19621 Hillside Ave, Hollis, NY 11423 Phone: 718-776-3129 Fax: 718-776-3224 | |
Ms. Sima Hertzberg, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8674 Palermo St, Hollis, NY 11423 Phone: 718-479-8118 | |
Michael Joseph Novack, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8815 182nd St, Hollis, NY 11423 Phone: 718-297-9821 |